Kewaunee Scientific (NASDAQ:KEQU) Share Price Crosses Above 200 Day Moving Average - Should You Sell?

Key Points

• Kewaunee Scientific shares briefly moved above their 200-day moving average of $36.91, reaching $36.97 before last trading at $35.55 on light volume.
• Analyst sentiment remains cautious: Weiss Ratings reaffirmed a “hold (C)” rating, and the sole analyst tracked by MarketBeat also rates the stock “Hold.”
• The company reported quarterly EPS of $0.58 on revenue of $66.32 million, with a 2.97% net margin and 11.61% return on equity; institutional investors own 32.69% of the shares.

Shares of Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $36.91 and traded as high as $36.97. Kewaunee Scientific shares last traded at $35.55, with a volume of 544 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a "hold (c)" rating on shares of Kewaunee Scientific in a research report on Tuesday, June 30th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Kewaunee Scientific presently has a consensus rating of "Hold".

Kewaunee Scientific Price Performance

The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.55 and a current ratio of 2.20. The company has a 50-day moving average of $36.60 and a 200-day moving average of $36.91. The firm has a market capitalization of $103.09 million, a price-to-earnings ratio of 12.88 and a beta of 0.73.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, September 9th. The technology company reported $0.58 EPS for the quarter. Kewaunee Scientific had a net margin of 2.97% and a return on equity of 11.61%. The firm had revenue of $66.32 million for the quarter.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently made changes to their positions in KEQU. Punch & Associates Investment Management Inc. acquired a new position in Kewaunee Scientific in the 2nd quarter worth $3,749,000. De Lisle Partners LLP acquired a new stake in shares of Kewaunee Scientific in the 2nd quarter valued at about $1,919,000. BlackRock Inc. acquired a new stake in shares of Kewaunee Scientific in the 2nd quarter valued at about $425,000. Royce & Associates LP raised its stake in shares of Kewaunee Scientific by 18.0% in the 4th quarter. Royce & Associates LP now owns 46,000 shares of the technology company's stock valued at $1,721,000 after purchasing an additional 7,010 shares during the period. Finally, Minerva Advisors LLC lifted its holdings in shares of Kewaunee Scientific by 51.8% in the fourth quarter. Minerva Advisors LLC now owns 121,863 shares of the technology company's stock valued at $4,559,000 after purchasing an additional 41,589 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures and installs laboratory, healthcare and technical furniture and related products. Its offerings include laboratory casework, steel and wood cabinets, countertops, sinks, storage systems, fume hoods, workstations and other specialized equipment used in research, education, healthcare, industrial and government facilities.

The company provides laboratory planning, design and installation services in addition to its manufactured products, supporting projects ranging from individual laboratory upgrades to larger, turnkey facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.